OnabotulinumtoxinA (BOTOX®)A Review of its Use in the Prophylaxis of Headaches in Adults with Chronic Migraine

被引：0
|
作者：
James E. Frampton
机构：
[1] Adis,
来源：
Drugs | 2012年 / 72卷
关键词：
Migraine; Topiramate; Chronic Migraine; Medication Overuse; OnabotulinumtoxinA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This article reviews the pharmacology, therapeutic efficacy and tolerability profile of intramuscularly injected onabotulinumtoxinA (onaBoNTA; BOTOX®) for headache prophylaxis in adults with chronic migraine, with a focus on UK labelling for the drug. The pharmacological actions of onaBoNTA include a direct antinociceptive (analgesic) effect; while not fully understood, the mechanism of action underlying its headache prophylaxis effect in chronic migraine is presumed to involve inhibition of peripheral and central sensitization in trigemino-vascular neurones.
引用
收藏
页码：825 / 845
页数：20
相关论文
共 50 条
  • [1] OnabotulinumtoxinA (BOTOX®) A Review of its Use in the Prophylaxis of Headaches in Adults with Chronic Migraine
    Frampton, James E.
    DRUGS, 2012, 72 (06) : 825 - 845
  • [2] OnabotulinumtoxinA (BOTOX®): A Guide to Its Use in Preventing Headaches in Adults with Chronic Migraine
    Katherine A. Lyseng-Williamson
    James E. Frampton
    CNS Drugs, 2012, 26 : 717 - 723
  • [3] OnabotulinumtoxinA (BOTOX®): A Guide to Its Use in Preventing Headaches in Adults with Chronic Migraine
    Lyseng-Williamson, Katherine A.
    Frampton, James E.
    CNS DRUGS, 2012, 26 (08) : 717 - 723
  • [4] Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks
    Oterino, A.
    Ramon, C.
    Pascual, J.
    JOURNAL OF HEADACHE AND PAIN, 2011, 12 (02): : 235 - 238
  • [5] OnabotulinumtoxinA in Migraine and Other Headaches: Review and Update
    Marc E. Lenaerts
    Tiffany H. Green
    Current Treatment Options in Neurology, 2019, 21
  • [6] OnabotulinumtoxinA in Migraine and Other Headaches: Review and Update
    Lenaerts, Marc E.
    Green, Tiffany H.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2019, 21 (04)
  • [7] OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use
    Frampton, James E.
    CNS DRUGS, 2020, 34 (12) : 1287 - 1298
  • [8] Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks
    A. Oterino
    C. Ramón
    J. Pascual
    The Journal of Headache and Pain, 2011, 12 : 235 - 238
  • [9] OnabotulinumtoxinA for the prophylactic treatment of headaches in adult patients with chronic migraine: a safety evaluation
    Cheng, Fan
    Ahmed, Fayyaz
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (11) : 1275 - 1289
  • [10] Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
    Santos-Lasaosa, S.
    Cuadrado, M. L.
    Gago-Veiga, A. B.
    Guerrero-Peral, A. L.
    Irimia, P.
    Lainez, J. M.
    Leira, R.
    Pascual, J.
    Porta-Etessam, J.
    Sanchez del Rio, M.
    Viguera Romero, J.
    Pozo-Rosich, P.
    NEUROLOGIA, 2020, 35 (08): : 568 - 578
12345